ServicenavigationHauptnavigationTrailKarteikarten


Research unit
INNOSUISSE
Project number
40379.1 IP-LS
Project title
Developing a next-generation targeted anti-fibrotic therapy for heart failure in a porcine model

Participants

Research organisation: Innosuisse
Swiss Innovation Agency
Einsteinstrasse 2
CH-3003 Bern
+41 58 461 61 61 (Call Center)
info@innosuisse.ch
www.innosuisse.ch/
Contact person

Robert Rieben
Universität Bern
DBMR
Murtenstrasse 35
CH-3008 Bern
+41316329669
robert.rieben@dbmr.unibe.ch


Main Implementation Partner

Doktor
Daniel Blessing
HAYA Therapeutics SA
Startlab, Route De La Corniche 5
CH-1066 Epalinges
+41787439766
daniel@hayatx.com